A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France.
about
Developing Michigan Cancer Foundation 7 Cells with Stable Expression of E7 Gene of Human Papillomavirus Type 16.Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs.Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis.Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia
P2860
A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A comparative analysis of the ...... ngs of HPV vaccines in France.
@en
A comparative analysis of the ...... ngs of HPV vaccines in France.
@nl
type
label
A comparative analysis of the ...... ngs of HPV vaccines in France.
@en
A comparative analysis of the ...... ngs of HPV vaccines in France.
@nl
prefLabel
A comparative analysis of the ...... ngs of HPV vaccines in France.
@en
A comparative analysis of the ...... ngs of HPV vaccines in France.
@nl
P2093
P2860
P356
P1476
A comparative analysis of the ...... ngs of HPV vaccines in France.
@en
P2093
Marjorie Adam
Nathalie Largeron
Rémi Marty
Stephane Roze
Xavier Bresse
P2860
P304
P356
10.4161/HV.22994
P577
2013-04-01T00:00:00Z